Zawya

CMA launches application for smartphones

04 April 2012 The Capital Market Authority (CMA) launched its application for smartphones yesterday in an effort to reach the maximum number of current and potential future investors in the capital ...
Truckinginfo

CMA Launches New Double Coin Tires Mobile Application

Double Coin Tires and CMA launched of a new Double Coin Tires mobile application available for Apple iPhone and Androidsmartphones. The free Double Coin Tires mobile application uses GPS and offers ...
Business Insider

ChemoCentryx Announces Withdrawal of Phase II-Based Conditional Marketing Authorization (CMA) Application for ANCA-Associated Vasculitis in Europe; Phase III ADVOCATE Trial ...

MOUNTAIN VIEW, Calif. and ZURICH, Switzerland, Jan. 24, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. and Vifor Fresenius Medical Care Renal Pharma Ltd., a company of Vifor Pharma Group, today announced ...
Zawya

CMA launches smart phone application to woo investors

CMA launches smart phone application to woo investors The Saudi Capital Market Authority (CMA) launched its application for smart phones in an effort to reach the maximum number of current and ...
Business Wire

CSL Vifor and Travere Therapeutics announce EMA has accepted for review the Conditional Marketing Authorization application for sparsentan for the treatment of IgA Nephropathy

ST. GALLEN, Switzerland & SAN DIEGO--(BUSINESS WIRE)--CSL Vifor and Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the EMA has accepted for review the Conditional Marketing ...
Nasdaq

EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster

Moderna MRNA announced that the European Medicines Agency accepted its conditional marketing authorization (CMA) application seeking approval to use a 50-µg booster dose of its bivalent BA.4/BA.5 ...
Business Wire

ChemoCentryx Announces Withdrawal of Phase II-Based Conditional Marketing Authorisation (CMA) Application for ANCA-Associated Vasculitis in Europe, Phase III Advocate Trial ...

ZURICH & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Regulatory News: ChemoCentryx, Inc. and Vifor Fresenius Medical Care Renal Pharma Ltd., a company of Vifor Pharma Group, today announced that in light ...